Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

FDA and Genentech issue warning on Avastin

Aug. 18, 2004

New HSP90 inhibitors and their use in cancer and other disorders

Aug. 18, 2004

Swiss approval for Femara as extended adjuvant treatment

Aug. 18, 2004

Combined immunostimulatory treatment enhances antitumor activity in vivo

Aug. 18, 2004

NeuroSearch and TopoTarget collaborate on Endovion development

Aug. 17, 2004

Spectrum acquires North American, Indian rights to D-631153

Aug. 17, 2004

Novartis exercises option to Vernalis' lead Hsp90 oncology program

Aug. 16, 2004

Pharmacia presents new CDK inhibitors

Aug. 16, 2004

European orphan drug designation for TheraCIM hR3

Aug. 16, 2004

Array BioPharma and QLT collaborate in cancer therapeutics discovery

Aug. 16, 2004

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...